Global High Throughput Screening Market is Set for a Positive Growth Forecast at CAGR of 7.8% till 2023
Bharat Book Bureau Provides the Trending Market Research Report on “Global High Throughput Screening Market, Forecast to 2023” under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.
Global high-throughput screening (HTS) market projected to grow at a CAGR of 7.8%
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.
Request a free sample copy of High Throughput Screening Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/321089
The software segment is expected to register the highest CAGR during the forecast period
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.
Contract research organizations are expected to grow at the fastest rate during the forecast period
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.
APAC is projected to witness the highest growth during the forecast period
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–31%, Tier 2–46% and Tier 3–23%
- By Designation – C-level–42%, Director Level–26%, Others–32%
- By Region – North America–35%, Europe–30%, Asia Pacific–21%, RoW–14%
The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
Click the link below to read the Full report :
https://www.bharatbook.com/MarketReports/High-Throughput-Screening-Market-by-Technology-Cell-Based-Assays-Lab-on-a-Chip-Bioinformatics-Application-Target-Identif/321089
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Global high-throughput screening (HTS) market projected to grow at a CAGR of 7.8%
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.
Request a free sample copy of High Throughput Screening Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/321089
The software segment is expected to register the highest CAGR during the forecast period
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.
Contract research organizations are expected to grow at the fastest rate during the forecast period
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.
APAC is projected to witness the highest growth during the forecast period
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–31%, Tier 2–46% and Tier 3–23%
- By Designation – C-level–42%, Director Level–26%, Others–32%
- By Region – North America–35%, Europe–30%, Asia Pacific–21%, RoW–14%
The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
Click the link below to read the Full report :
https://www.bharatbook.com/MarketReports/High-Throughput-Screening-Market-by-Technology-Cell-Based-Assays-Lab-on-a-Chip-Bioinformatics-Application-Target-Identif/321089
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Comments
Post a Comment